These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21267033)

  • 41. [Anakinra treatment in Schnitzler syndrome -  results of the first retrospective multicenter study in six patients from the Czech Republic].
    Szturz P; Sedivá A; Zurek M; Adam Z; Stork J; Cermáková Z; Steyerová P; Vokáčová A; Hrbek J; Sýkora M; Spička I; Mechl Z; Mayer J
    Klin Onkol; 2014; 27(2):111-26. PubMed ID: 24739048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pivot and Cluster: An Exercise in Clinical Reasoning.
    May JE; Blackburn RJ; Centor RM; Dhaliwal G
    J Gen Intern Med; 2018 Feb; 33(2):226-230. PubMed ID: 29185175
    [No Abstract]   [Full Text] [Related]  

  • 43. Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome.
    Hodl I; Bosch P; Dreo B; Stradner MH
    Front Immunol; 2020; 11():576200. PubMed ID: 33123160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Schnitzler syndrome in a patient with a family history of monoclonal gammopathy.
    Wilmas K; Aria A; Torres-Cabala CA; Lu H; Duvic M
    Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schnitzler's syndrome: a diagnostic conundrum.
    Fairris C; Darvay A
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24966258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schnitzler syndrome with IgG gammopathy and elevated IL-1β and IL-17 in skin biopsy.
    Villarreal RS; VandenBoom T; Gonzalez-Gonzalez FJ; Carter RG; Peters NT; Peters AT; Chiarella SE
    Ann Allergy Asthma Immunol; 2018 Jan; 120(1):99-101. PubMed ID: 29162318
    [No Abstract]   [Full Text] [Related]  

  • 47. Schnitzler syndrome: A rare cause of chronic recalcitrant urticaria successfully treated with Anakinra.
    Sharma S; Joske D; Watson D; Caccetta T; Baltic S; Kumarasinghe SP
    Australas J Dermatol; 2018 Aug; 59(3):e222-e224. PubMed ID: 29027204
    [No Abstract]   [Full Text] [Related]  

  • 48. Prompt response of refractory Schnitzler syndrome to treatment with anakinra.
    Schneider SW; Gaubitz M; Luger TA; Bonsmann G
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S120-2. PubMed ID: 17434038
    [No Abstract]   [Full Text] [Related]  

  • 49. Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra.
    Longhurst HJ; Yong PF; Manson AL; Cavenagh JD; Grigoriadou S; Buckland MS
    QJM; 2015 Jun; 108(6):497-501. PubMed ID: 23108029
    [No Abstract]   [Full Text] [Related]  

  • 50. Schnitzler syndrome: chronic urticaria, fever and immunoglobulin M monoclonal gammopathy.
    Shibolet O; Schatz O; Krieger M; Maly A; Caraco Y
    Isr Med Assoc J; 2002 Jun; 4(6):466-7. PubMed ID: 12073428
    [No Abstract]   [Full Text] [Related]  

  • 51. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First observation of the efficacy of IL-1ra to treat tophaceous gout of the lumbar spine.
    Funck-Brentano T; Salliot C; Leboime A; Zafrani L; Servais A; Larousserie F; Dougados M
    Rheumatology (Oxford); 2011 Mar; 50(3):622-4. PubMed ID: 21097448
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anakinra and Schnitzler's syndrome].
    Saiz E; Gálvez J; Mora A; Contreras L
    Med Clin (Barc); 2008 Mar; 130(9):358-9. PubMed ID: 18373918
    [No Abstract]   [Full Text] [Related]  

  • 54. Chronic vasculitis urticaria associated to a monoclonal gammopathy of IgM and IgA type, a Schnitzler Syndrome?
    Carlesimo M; Abruzzese C; Narcisi A; La Verde G; De Marco G; Verga E; Fidanza L; Camplone G
    Eur J Dermatol; 2010; 20(6):838-9. PubMed ID: 20956107
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 57. Beyond Urticaria: Schnitzler Syndrome.
    Ruiz-Villaverde R; Bueno-Rodriguez A; Sánchez-Cano D
    Balkan Med J; 2017 Sep; 34(5):478-479. PubMed ID: 28552842
    [No Abstract]   [Full Text] [Related]  

  • 58. Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.
    Becker ML; Funk RS
    Clin Transl Sci; 2018 Mar; 11(2):106-108. PubMed ID: 29193724
    [No Abstract]   [Full Text] [Related]  

  • 59. Macrophage activation syndrome treated with anakinra.
    Durand M; Troyanov Y; Laflamme P; Gregoire G
    J Rheumatol; 2010 Apr; 37(4):879-80. PubMed ID: 20360206
    [No Abstract]   [Full Text] [Related]  

  • 60. Variable Responses to Tocilizumab in Four Patients with Schnitzler Syndrome.
    Claus J; Vanderschueren S
    J Clin Immunol; 2019 May; 39(4):370-372. PubMed ID: 31111419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.